ALK-28

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameALK-28
Drug Alias NameALK28
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkion Biopharma SAS
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A